D.E. Shaw & Co’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,073,491
| Closed | -$396K | – | 5064 |
|
|
2022
Q4 | $396K | Sell |
1,073,491
-2,771,497
| -72% | -$1.17M | ﹤0.01% | 3975 |
|
|
2022
Q3 | $1.65M | Sell |
3,844,988
-4,206,870
| -52% | -$4.13M | ﹤0.01% | 3169 |
|
|
2022
Q2 | $6.28M | Buy |
8,051,858
+206,132
| +3% | +$182K | 0.01% | 1859 |
|
|
2022
Q1 | $10.1M | Buy |
7,845,726
+6,983,089
| +810% | +$6.43M | 0.01% | 1574 |
|
|
2021
Q4 | $1.1M | Buy |
862,637
+610,012
| +241% | +$1.09M | ﹤0.01% | 3857 |
|
|
2021
Q3 | $550K | Sell |
252,625
-320,773
| -56% | -$876K | ﹤0.01% | 4025 |
|
|
2021
Q2 | $2.15M | Buy |
573,398
+49,559
| +9% | +$172K | ﹤0.01% | 2868 |
|
|
2021
Q1 | $1.71M | Sell |
523,839
-608,001
| -54% | -$2.18M | ﹤0.01% | 2726 |
|
|
2020
Q4 | $3.86M | Buy |
1,131,840
+191,056
| +20% | +$786K | ﹤0.01% | 2072 |
|
|
2020
Q3 | $3.84M | Sell |
940,784
-617,291
| -40% | -$2.35M | ﹤0.01% | 1890 |
|
|
2020
Q2 | $5.27M | Buy |
1,558,075
+887,469
| +132% | +$2.59M | 0.01% | 1635 |
|
|
2020
Q1 | $1.56M | Buy |
670,606
+443,298
| +195% | +$1.21M | ﹤0.01% | 2371 |
|
|
2019
Q4 | $827K | Buy |
+227,308
| New | +$1.84M | ﹤0.01% | 3112 |
|
|
2018
Q4 | – | Sell |
-40,426
| Closed | -$679K | – | 4071 |
|
|
2018
Q3 | $679K | Sell |
40,426
-387,421
| -91% | -$8.38M | ﹤0.01% | 2939 |
|
|
2018
Q2 | $8.97M | Sell |
427,847
-942,770
| -69% | -$17.5M | 0.01% | 1150 |
|
|
2018
Q1 | $22.1M | Sell |
1,370,617
-617,860
| -31% | -$12.2M | 0.03% | 613 |
|
|
2017
Q4 | $37.7M | Sell |
1,988,477
-860,691
| -30% | -$15.6M | 0.05% | 433 |
|
|
2017
Q3 | $40.1M | Buy |
2,849,168
+370,381
| +15% | +$3.35M | 0.06% | 378 |
|
|
2017
Q2 | $18.5M | Buy |
2,478,787
+103,939
| +4% | +$679K | 0.03% | 619 |
|
|
2017
Q1 | $15.4M | Buy |
2,374,848
+264,953
| +13% | +$1.48M | 0.03% | 698 |
|
|
2016
Q4 | $9.35M | Buy |
2,109,895
+90,525
| +4% | +$380K | 0.02% | 973 |
|
|
2016
Q3 | $9.43M | Sell |
2,019,370
-89,244
| -4% | -$529K | 0.02% | 923 |
|
|
2016
Q2 | $13.9M | Buy |
2,108,614
+869,854
| +70% | +$6.15M | 0.03% | 707 |
|
|
2016
Q1 | $7.88M | Buy |
1,238,760
+251,650
| +25% | +$1.29M | 0.01% | 994 |
|
|
2015
Q4 | $5.95M | Buy |
987,110
+476,476
| +93% | +$2.73M | 0.01% | 1281 |
|
|
2015
Q3 | $3.05M | Buy |
510,634
+462,425
| +959% | +$3.21M | ﹤0.01% | 1762 |
|
|
2015
Q2 | $330K | Sell |
48,209
-31,682
| -40% | -$201K | ﹤0.01% | 3375 |
|
|
2015
Q1 | $485K | Buy |
+79,891
| New | +$532K | ﹤0.01% | 3060 |
|
|
2014
Q3 | – | Sell |
-133,573
| Closed | -$1.09M | – | 4454 |
|
|
2014
Q2 | $1.09M | Buy |
133,573
+112,876
| +545% | +$856K | ﹤0.01% | 2861 |
|
|
2014
Q1 | $162K | Sell |
20,697
-265,399
| -93% | -$2.25M | ﹤0.01% | 4125 |
|
|
2013
Q4 | $2.53M | Sell |
286,096
-1,041,965
| -78% | -$9.31M | ﹤0.01% | 2303 |
|
|
2013
Q3 | $11.1M | Buy |
1,328,061
+125,780
| +10% | +$1.02M | 0.02% | 922 |
|
|
2013
Q2 | $8.97M | Buy |
+1,202,281
| New | +$9.22M | 0.02% | 933 |
|
Other funds holding SPPI
AC
SIG
ACM
D.E. Shaw & Co's SPPI Position: Q1 2023 in Review
D.E. Shaw & Co sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2023, closing a stake of 1,073,491 shares — an estimated $396K sold.
D.E. Shaw & Co first reported a position in SPPI in Q2 2013 and held it in 33 quarters. The position peaked at $40.1M in Q3 2017. 69 funds tracked by Wall St. Rank hold SPPI as of Q1 2023.
- D.E. Shaw & Co reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2023 after selling out during the quarter.
- D.E. Shaw & Co sold 1,073,491 Spectrum Pharmaceuticals Inc shares in Q1 2023, an estimated $396K.
- D.E. Shaw & Co first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
- D.E. Shaw & Co's Spectrum Pharmaceuticals Inc position peaked at $40.1M in Q3 2017.
- 69 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2023.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.